title: Plasma resistin levels and risk of myocardial infarction and ischemic stroke.
abstract: BACKGROUND
  Resistin is a hormone that has been linked to insulin resistance, inflammatory processes, and coronary heart disease in case-control studies; however, prospective data on the association between plasma resistin levels and future risk of cardiovascular disease are lacking.
  
  
  OBJECTIVE
  The objective of the study was to investigate the association between plasma resistin levels and risk of future myocardial infarction (MI) and ischemic stroke (IS) in a large prospective cohort.
  
  
  METHODS
  We investigated the association between plasma resistin levels and risk of MI and IS in a case-cohort design among 26,490 middle-aged subjects from the European Investigation into Cancer and Nutrition-Potsdam Study without history of MI or stroke at time of blood draw. Plasma resistin levels were measured in baseline blood samples of 139 individuals who developed MI, 97 who developed IS, and 817 individuals who remained free of cardiovascular events during a mean follow-up of 6 yr.
  
  
  RESULTS
  After multivariable adjustment for established cardiovascular risk factors including C-reactive protein, individuals in the highest compared with the lowest quartile of plasma resistin levels had a significantly increased risk of MI (relative risk 2.09; 95% confidence interval 1.01-4.31; P for trend = 0.01). In contrast, plasma resistin levels were not significantly associated with risk of IS (relative risk 0.94; 95% confidence interval 0.51-1.73; P for trend = 0.88).
  
  
  CONCLUSIONS
  Our data suggest that high plasma resistin levels are associated with an increased risk of MI but not with risk of IS. Further studies are needed to evaluate the predictive value of plasma resistin levels for cardiovascular disease.
authors.affiliation: Department of Epidemiology, German Institute of Human Nutrition, Arthur-Scheunert-Allee 114-116, Nuthetal, Germany. weikert@dife.de
authors.forename: Cornelia
authors.initials: C
authors.lastname: Weikert
authors.forename: Sabine
authors.initials: S
authors.lastname: Westphal
authors.forename: Klaus
authors.initials: K
authors.lastname: Berger
authors.forename: Jutta
authors.initials: J
authors.lastname: Dierkes
authors.forename: Matthias
authors.initials: M
authors.lastname: Möhlig
authors.forename: Joachim
authors.initials: J
authors.lastname: Spranger
authors.forename: Eric B
authors.initials: EB
authors.lastname: Rimm
authors.forename: Stefan N
authors.initials: SN
authors.lastname: Willich
authors.forename: Heiner
authors.initials: H
authors.lastname: Boeing
authors.forename: Tobias
authors.initials: T
authors.lastname: Pischon
mesh_terms: D000328:Adult; D002545:Brain Ischemia / Q000097:blood / Q000209:etiology*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000097:blood / Q000209:etiology*; D011446:Prospective Studies; D052243:Resistin / Q000097:blood*; D012307:Risk Factors; D020521:Stroke / Q000097:blood / Q000209:etiology*
chemical_list: C499624:RETN protein, human; D052243:Resistin